BlackRock, Inc. 13D and 13G filings for Acumen Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-07 2:58 pm Sale | 2022-09-30 | 13G | Acumen Pharmaceuticals, Inc. ABOS | BlackRock Inc. BLK | 1,115,027 2.800% | -1,994,643 (-64.14%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | BlackRock Inc. BLK | 3,109,670 7.700% | 3,109,670 (New Position) | Filing |